Temozolomide is effective and well tolerated in patients with primary vitreoretinal lymphoma
Marine Baron, Lisa Belin, Nathalie Cassoux, Christine Fardeau, M. Blaizeau, Carole Soussain, Caroline Houillier, Khê Hoang‐Xuan, Emmanuel Gyan, Marie‐Laure Le Lez, Anne Lavaud, Pierre Soubeyran, Bahram Bodaghi, Myrto Costopoulos, Véronique Leblond, Valérie Touitou, Karim Maloum, Marie‐Hélène Errera, Damien Roos‐Weil, Magali Le Garff‐Tavernier, Sylvain Choquet
Abstract
Baron et al report excellent responses to temozolomide in 21 patients (19 relapsed/refractory) with primary vitreoretinal lymphoma. Treatment is well tolerated, even in elderly patients.
Topics & Concepts
TemozolomideMedicineLymphomaRefractory (planetary science)Internal medicineOncologyDacarbazineSurgeryChemotherapyAstrobiologyPhysicsCNS Lymphoma Diagnosis and TreatmentLymphoma Diagnosis and TreatmentVascular Tumors and Angiosarcomas